Your browser doesn't support javascript.
loading
Advances in targeted therapy for childhood acute myeloid leukemia / 中国当代儿科杂志
Chinese Journal of Contemporary Pediatrics ; (12): 832-836, 2017.
Artículo en Chino | WPRIM | ID: wpr-297199
ABSTRACT
At present, acute myeloid leukemia (AML) accounts for about 15%-20% of childhood acute leukemia. Although overall survival rate is increasing with the help of risk stratification, stratification of chemotherapy, and supportive treatment, conventional pharmacotherapy still has a limited clinical effect and certain limitations in improving remission rate in previously untreated patients and reducing recurrence after remission. With the development of precision medicine, the mechanisms of targeted therapy, including abnormal activation of AML-related signaling pathways and epigenetic modification, have been found in recent years. Molecular-targeted drugs can therefore act on specific receptors and target genes to improve clinical effect and the prognosis of AML patients.
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Leucemia Mieloide Aguda / Mortalidad / Epigénesis Genética / Quimioterapia / Terapia Molecular Dirigida / Inmunoterapia Tipo de estudio: Estudio pronóstico Límite: Niño / Humanos Idioma: Chino Revista: Chinese Journal of Contemporary Pediatrics Año: 2017 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Leucemia Mieloide Aguda / Mortalidad / Epigénesis Genética / Quimioterapia / Terapia Molecular Dirigida / Inmunoterapia Tipo de estudio: Estudio pronóstico Límite: Niño / Humanos Idioma: Chino Revista: Chinese Journal of Contemporary Pediatrics Año: 2017 Tipo del documento: Artículo